Back to results
US 2020/0048249 A1Published application
Ptpn11 inhibitors
AssigneeBoard of Regents, The University of Texas System
InventorsPhilip JONES, Barbara CZAKO, Christopher L. CARROLL, Pijus MANDAL, Jason CROSS
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds which are useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
Claims33
A compound represented by Formula I
- or a salt, ester, or prodrug thereof, wherein:
- subscript a is 0 or 1;
- subscript b is 0 or 1;
- Y1 is a direct bond or CR17R18;
- Y2 is selected from the group consisting of C1-4alkyl, amino, C1-4alkylC(O)O—, C1-4alkylamino and C1-4aminoalkyl;
- R1 is selected from the group consisting of C6-10aryl, C3-8cycloalkyl, C3-8cycloalkenyl, and a 5-10 membered heteroaryl group having 1 to 4 heteroatoms or groups as ring vertices independently selected from N, C(O), O, and S;
- said aryl or heteroaryl of R1 is optionally substituted with 1 to 5 R12 groups independently selected from the group consisting of halo, hydroxy, amino, C1-4alkylamino, di(C1-4alkyl)amino, cyano, C1-4alkyl, C1-4alkoxy, C1-4hydroxyalkyl, C1-4haloalkyl, C1-4aminoalkyl, C3-8cycloalkyl, C3-8cycloalkenyl, NR15C(O)R14, NR15C(O)OR14, NR14C(O)NR15R16, NR15S(O)R14, NR15S(O)2R14, C(O)NR15R16, S(O)NR15R16, S(O)2NR15R16, C(O)R14, C(O)OR14, OR14, SR14, S(O)R14, and S(O)2R14;
- R2, R3, R10, and R11 are each independently selected from the group consisting of hydrogen, C1-4alkyl, and C3-8cycloalkyl;
- R4, R5, R8, and R9 are each independently selected from the group consisting of hydrogen, cyano, C1-4alkyl, C1-4alkoxy, amino, hydroxy, C3-8cycloalkyl, halo, and C1-4alkylamino;
- R6 is selected from the group consisting of amino, C1-4aminoalkyl, and C1-4alkylamino;
- R7 is selected from the group consisting of hydrogen, amido, cyano, halo, and hydroxy, or is selected from the group consisting of C1-4alkyl, C1-4hydroxyalkyl, C3-6cycloalkyl, phenyl, and 5- or 6-membered heteroaryl, any of which is optionally substituted with one to five groups independently selected from the group consisting of amino, halo, hydroxy, cyano, C1-4alkyl, C1-4alkoxy, C1-4haloalkyl, C1-4haloalkoxy, C1-4alkylamino, and C1-4aminoalkyl;
- or R6 and R7 together with the carbon atom to which they are both attached form a 3- to 7-membered saturated or unsaturated ring, having 0 to 3 heteroatoms or groups as ring vertices independently selected from N, C(O), O, and S(O)m;
- subscript m is 0, 1, or 2;
- said saturated or unsaturated ring formed by R6 and R7 is unsubstituted or substituted with 1 to 3 groups independently selected from the group consisting of amino, halo, hydroxy, cyano, C1-4alkyl, C1-4alkoxy, C1-4haloalkyl, C1-4haloalkoxy, C1-4alkylamino and C1-4aminoalkyl;
- any two groups of R2, R3, R4, R5, R7, R8, R9, R10 and R11 can form a 5 to 6 membered ring, having 0 to 2 heteroatoms as ring verticess elected from N, O and S;
- any two groups of R2, R4, R6, R8 and R10 can form a direct bond, or a 1 or 2 atom carbon bridge;
- R13 is selected from the group consisting of hydrogen, halo, cyano, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C1-6 dihydroxyalkyl, —NH—NHR19, —NHR19, —OR19, —NHC(O)R19, —NHC(O)NHR19, —NHS(O)2NHR19, —NHS(O)2R19, —C(O)OR19, —C(O)NR19R20, —C(O)NH(CH2)qOH, —C(O)NH(CH2)qR21, —C(O)R21, —NH2, —OH, —S(O)2NR19R20, C3-8cycloalkyl, aryl, heterocyclyl having 1-5 heteroatoms as ring vertices selected from N, O, S and P, heteroaryl having 1-5 heteroatoms as ring vertices selected from N, O, S and P;
- wherein the subscript q is an integer of from 0 to 6;
- and wherein aryl, heteroaryl, heterocyclyl and cycloalkyl are substituted with 0 to 3 groups independently selected from the group consisting of C1-4alkyl, —OH, —NH2, —OR21, halo, cyano, and oxo;
- R14, R15 and R16 are each independently selected from the group consisting of hydrogen, C1-4alkyl, C3-8cycloalkyl, C6-10aryl and 5-10 membered heteroaryl, each of which is optionally substituted by one or more groups independently selected from the group consisting of amido, amino, halo, hydroxy, cyano, C1-4alkyl, C1-4alkoxy, C1-4haloalkyl, C1-4haloalkoxy, C1-4alkylamino and C1-4aminoalkyl;
- R17 and R18 are each independently selected from the group consisting of hydrogen, C1-4alkyl, and CF3;
- R19 and R20 are each independently selected from the group consisting of hydrogen, C1-6alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C2-6alkenyl, C2-6alkynyl and C3-6cycloalkyl;
- and
- each R21 is independently selected from the group consisting of hydrogen, —OH, C1-6 alkyl, C1-6haloalkyl, C1-6hydroxyalkyl, C2-6alkenyl, C2-6alkynyl and C3-6cycloalkyl.
21 more elements
(canceled)
(canceled)
(canceled)
22-23. (canceled)
28-32. (canceled)
(canceled)
38-40. (canceled)
Dependencies are inferred from the claim text.